Metabolic disorders were evaluated in rats with alloxan diabetes mellitus after administration of 2-morpholino-5-phenyl-6H-1,3,4-thiadiazine (compound L-17). Administration of L-17 reduced the severity of metabolic disorders associated with diabetes mellitus. At the end of the experiment, the concentration of glucose, glycated hemoglobin, malonic dialdehyde, and catalase activity were significantly higher and peroxidase activity was significantly lower in the group of animals receiving L-17. The decrease of glycemia, glucose concentration, and glycated hemoglobin content was reached by the 3rd-4th week of the experiment. These data suggest that correction of biochemical parameters in rats with alloxan diabetes was reached after administration of L-17 for at least 3 weeks.
This is a preview of subscription content, log in via an institution to check access.
References
Volchegorskii IA, Rassokhina LM, Miroshnichenko IY. Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes. Bull. Exp. Biol. Med. 2013;155(1):56-64.
Emel’yanov VV, Savateeva EA, Sidorova LP, Tsqitler TA, Bulavintseva TS, Gette IF, Danilova IG, Maksimova NE, Mochul’skaya NN, Chupakhin ON, Chereshnev VA. Correction of metabolic disorders in alloxan diabetes with 1,3,4-thiadiazine derivatives. Ross. Immun. Zh. 2015;9(2):487-489. Russian.
Medvedeva SYu, Bulavintseva TS, Danilova IG, Gette IF, Sentsov VG. The toxic effect of alloxan in the dynamics of the development of alloxan diabetes. Vestn. Ural. Med. Akad. Nauki. 2012(3):30-33. Russian.
Mozheyko LA. Experimental models for studying diabetes mellitus part 1. Alloxan diabetes. Zh. Grodn. Gos. Univer. 2013(3):26-29. Russian.
Perova NM, Egorova LG, Sidorova LP, Novikova AP, Chupakhin ON. Desulfuration of 2-dialkylamino-5-phenyl-6H-1,3,4- thiadiazines to pyrazoles in acidic and alkaline media. Zh. Org. Khimii. 1994;30(Issue 10):1560-1565. Russian.
Diabetes Miletus: Diagnostiks, Treatment, and Prevention. Dedova II, Shestakova MV, eds. Moscow, 2011. Russian.
Sidorova LP, Tseitler TA, Perova NM, Emel’yanov VV, Savateeva EA, Maksimova NE, Mochul’skaya NN, Chereshnev VA, Chupakhin ON. Synthesis of new 1,3,4-thiadiazines capable of inhibiting nonenzymatic glycosylation of proteins. Khim.-Farm. Zh. 2015;49(8):8-12. Russian.
Tessier FJ. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol. Biol. (Paris). 2010;58(3):214-219.
Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J. Diabetes Res. 2014;2014. doi: 10.1155/2014/137919.
Zeng J, Davies MJ. Protein and low molecular mass thiols as targets and inhibitors of glycation reactions. Chem. Res. Toxicol. 2006;19(12):1668-1676.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 7, pp. 42-45, July, 2016
Rights and permissions
About this article
Cite this article
Emelianov, V.V., Savateeva, E.A., Sidorova, L.P. et al. 2-Morpholino-5-Phenyl-6H-1,3,4-Thiadiazine Corrects Metabolic Disorders during the Development of Alloxan Diabetes Mellitus in Rats. Bull Exp Biol Med 162, 35–37 (2016). https://doi.org/10.1007/s10517-016-3538-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3538-4